Elicio Therapeutics shares plunged after the biotech firm priced a secondary offering at a significant discount to its Wednesday closing price. Shares fell 18% to $7.86 premarket.
Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public ...
Advanced Micro Devices shares fell to a 1-year low this week due to DeepSeek's AI chat assistant news. See why I continue to ...